XML 72 R62.htm IDEA: XBRL DOCUMENT v3.19.1
Supplemental Condensed Consolidating Financial Information - Schedule of Condensed Consolidating Statement of Cash Flows (Detail) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Cash flows from operating activities:    
Net income (loss) $ 1,181 $ 1,282
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Changes in operating assets and liabilities (1,194) (485)
Depreciation and amortization 619 553
Income taxes 269 246
Losses (gains) on sales of facilities 1 (405)
Amortization of debt issuance costs 8 8
Share-based compensation 62 60
Other 28 24
Net cash provided by (used in) operating activities 974 1,283
Cash flows from investing activities:    
Purchase of property and equipment (781) (694)
Acquisition of hospitals and health care entities (1,474) (379)
Disposition of hospitals and health care entities 30 767
Change in investments 36 11
Other 24 (40)
Net cash used in investing activities (2,165) (335)
Cash flows from financing activities:    
Issuance of long-term debt 1,500  
Net change in revolving credit facilities 460 270
Repayment of long-term debt (49) (50)
Distributions to noncontrolling interests (136) (92)
Payment of debt issuance costs (22) (2)
Payment of cash dividends (141) (123)
Repurchases of common stock (278) (423)
Other (118) (191)
Net cash provided by (used in) financing activities 1,216 (611)
Effect on exchange rate changes on cash and cash equivalents 4 17
Change in cash and cash equivalents 29 354
Cash and cash equivalents at beginning of period 502 732
Cash and cash equivalents at end of period 531 1,086
HCA Healthcare, Inc. Issuer [Member]    
Cash flows from operating activities:    
Net income (loss) 1,039 1,144
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Changes in operating assets and liabilities (15) (15)
Income taxes 269 246
Equity in earnings of affiliates (1,026) (1,090)
Other 25 21
Net cash provided by (used in) operating activities 292 306
Cash flows from financing activities:    
Payment of cash dividends (141) (123)
Repurchases of common stock (278) (423)
Changes in intercompany balances with affiliates, net 243 434
Other (116) (195)
Net cash provided by (used in) financing activities (292) (307)
Change in cash and cash equivalents   (1)
Cash and cash equivalents at beginning of period   1
HCA Inc. Issuer [Member]    
Cash flows from operating activities:    
Net income (loss) (764) (642)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Changes in operating assets and liabilities (101) (99)
Amortization of debt issuance costs 8 8
Net cash provided by (used in) operating activities (857) (733)
Cash flows from financing activities:    
Issuance of long-term debt 1,500  
Net change in revolving credit facilities 460 270
Repayment of long-term debt (23) (18)
Payment of debt issuance costs (22) (2)
Changes in intercompany balances with affiliates, net (1,058) 483
Net cash provided by (used in) financing activities 857 733
Subsidiary Guarantors [Member]    
Cash flows from operating activities:    
Net income (loss) 1,582 1,570
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Changes in operating assets and liabilities (600) (347)
Depreciation and amortization 355 323
Losses (gains) on sales of facilities 1 (395)
Share-based compensation 62 60
Other 5  
Net cash provided by (used in) operating activities 1,405 1,211
Cash flows from investing activities:    
Purchase of property and equipment (471) (413)
Acquisition of hospitals and health care entities (12) (373)
Disposition of hospitals and health care entities 30 767
Change in investments   13
Other (5) (48)
Net cash used in investing activities (458) (54)
Cash flows from financing activities:    
Repayment of long-term debt (16) (22)
Distributions to noncontrolling interests (25) (24)
Changes in intercompany balances with affiliates, net (941) (919)
Net cash provided by (used in) financing activities (982) (965)
Change in cash and cash equivalents (35) 192
Cash and cash equivalents at beginning of period 174 112
Cash and cash equivalents at end of period 139 304
Subsidiary Non-Guarantors [Member]    
Cash flows from operating activities:    
Net income (loss) 350 300
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Changes in operating assets and liabilities (478) (24)
Depreciation and amortization 264 230
Losses (gains) on sales of facilities   (10)
Other (2) 3
Net cash provided by (used in) operating activities 134 499
Cash flows from investing activities:    
Purchase of property and equipment (310) (281)
Acquisition of hospitals and health care entities (1,462) (6)
Change in investments 36 (2)
Other 29 8
Net cash used in investing activities (1,707) (281)
Cash flows from financing activities:    
Repayment of long-term debt (10) (10)
Distributions to noncontrolling interests (111) (68)
Changes in intercompany balances with affiliates, net 1,756 2
Other (2) 4
Net cash provided by (used in) financing activities 1,633 (72)
Effect on exchange rate changes on cash and cash equivalents 4 17
Change in cash and cash equivalents 64 163
Cash and cash equivalents at beginning of period 328 619
Cash and cash equivalents at end of period 392 782
Eliminations [Member]    
Cash flows from operating activities:    
Net income (loss) (1,026) (1,090)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Equity in earnings of affiliates $ 1,026 $ 1,090